Literature surveys indicate that quinoline derivatives possess diverse pharmacological activities, including antimicrobial (1), antimalarial (2), antiviral (3), antitumor (4), immunomodulatory (5), caspase-3 inhibition (6), antileishmanial (7), local anesthetic (8), antiarrhythmic (8) and anti-inflammatory activities (9). Also, thiosemicarbazones constitute one of the most versatile classes of compounds possessing a wide spectrum of activities. It has been reported that thiosemicarbazone derivatives possess antimicrobial (1, 10), antimalarial (11), antiamoebic (12) and antitumor (13) activities. They have been in the focus of interest of medicinal chemists in the past decades because of the outstanding biological activities exhibited by several derivatives incorporating the heterocyclic moiety. Similarly, it is well documented that thiazoline nucleus is associated with a vari- 5-Acyl-8-hydroxyquinoline-2-(3'-substituted-4'-aryl-2,3--dihydrothiazol-2'-ylidene)hydrazones, 5a-e to 10a-c, were prepared by the reaction of appropriate 5-acyl-8-hydroxyquinoline-4-substituted thiosemicarbazones 3a-e and phenacyl bromides 4a-e. Structures of the new compounds were verified on the basis of spectral and elemental analyses. Twenty-eight new compounds were tested for their possible antimicrobial activities. Most of the tested compounds showed weak to moderate antibacterial activity against most of the bacterial strains used in comparison with gatifloxacin as a reference drug. The test compounds showed weak to moderate antifungal activity against tested fungi in comparison with ketoconazole as a reference drug. On the other hand, the newly synthesized compounds were tested for their anti-inflammatory effects and most of them showed good to excellent anti-inflammatory activity compared to indomethacin. Moreover, ulcerogenicity and the median lethal dose (LD 50 ) of the most active anti-inflammatory compounds 6b and 9e were determined in mice; they were non-toxic at doses up to 400 mg kg -1 after i.p. administration.
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5-Acetyl-8-hydroxyquinoline-2-(3'-phenyl-4'-aryl-2,3-dihydrothiazol-2'-ylidene)-hydra zones (9a-e)
A solution of the thiosemicarbazone derivative 3e (0.504 g, 0.0015 mol), anhydrous sodium acetate (100 mg, 0.0012 mol) and the appropriate phenacyl bromide 4a-e (0.0015 mol) in absolute ethanol (30 mL) was stirred at room temperature for 10-15 h, concentrated and left overnight. The product was filtered, dried and crystallized from absolute ethanol (Scheme 1, Tables I and II) .
Antimicrobial activity
Antibacterial activity. -The synthesized compounds 5a-e to 10a-c were tested for their antibacterial activity in vitro in comparison with gatifloxacin as a reference drug using the standard agar disc diffusion method (19) resented by Escherichia coli (AUMC B69), Pseudomonas aeruginosa (AUMC B72), and Serratia marcescens (AUMC B67). Cell suspension of bacterial strains was prepared from 48-h old cultures on nutrient agar (NA) in sterile water. One milliliter of suspension was added to a Petri dish of 9 cm diameter and then 15 mL of NA was poured into the plate. The plate was shaken gently to homogenize the inocula.
Sterile 5-mm filter paper disc (Whatman, UK) was saturated with 10 mL of the solution of test compound and gatifloxacin as a reference drug (53 mmol mL -1 in DMSO). In addition, an other disc was impregnated with the solvent (DMSO) and served as a negative control. The discs were then dried for 1 h and placed in the center of each plate. The seeded plates were incubated at 35 ± 2°C for 24-48 h. The radii of inhibition zones (in mm) of triplicate sets were measured and the results are given in Table III .
Antifungal activity. -The synthesized compounds 5a-e to 10a-c were tested for their antifungal activity in vitro in comparison with ketoconazole as a reference drug using the standard agar disc diffusion method (19 Spore suspension in sterile distilled water was prepared from a 2-5 days old culture of the test fungi grown on Sabouraud agar (SA) media. The final spore concentration was nearly 5 × 10 4 spores mL -1 . About 15 mL of growth medium was added to sterilized Petri dishes of 9 cm diameter and inoculated with 1 mL of spore suspension. Plates were shaken gently to homogenize the inocula.
Sterile 5-mm filter paper disc (Whatman) was saturated with 10 mL of test compound solution and ketoconazole (40 mmol mL -1 in DMSO). In addition, another disc was impregnated with DMSO and served as a negative control. The discs were then dried for 1 h and placed in the center of each plate. The seeded plates were incubated at 28 ± 2°C for 7 days. The radii of inhibition zones (in mm) of triplicate sets were measured at successive intervals during the incubation period and the results are given in Table IV .
Anti-inflammatory activity
Male adult albino rats (120-150 g) and mice (25-30 g) were obtained from the animal house (Faculty of Medicine, Assiut University, Egypt). Animals were housed in separate cages 6 animals each, in temperature-controlled rooms at 25°C. Animals were al- Gatifloxacin  34  30  19  30  24  34 (-) -no inhibition a 53 mmol mL -1 in DMSO lowed free access to rodent chow and water and maintained at a 12 h light/dark cycle. Work was conducted in accordance with the internationally accepted principles for laboratory animals' use and care as found in the European Community Guidelines (20) and Institutional Ethical Committee Approval was obtained. Indomethacin (Liometacin ® vial, Nile Company, Egypt), carrageenan (Sigma, USA), sodium carboxymethylcellulose (NaCMC) and normal saline were obtained from the local market.
All tested compounds and the reference drug were suspended in 1 % NaCMC in normal saline. Suspensions of the tested compounds, reference drug and 1 % NaCMC--saline solution (negative control) were injected i.p. (1 mL each) .
The anti-inflammatory activity of the newly synthesized compounds 5a-e to 10a-c together with the intermediate compounds 3a-f was evaluated according to the carrageenan induced paw edema method in comparison with indomethacin as a reference drug (21) . The test is based on pedal inflammation in rat paws induced by subplantar injection of carrageenan suspension (0.2 mL of 1 % solution in normal saline) into the right hind paw of the rats. Male adult albino rats were divided into groups of four animals each. The rat paw thickness was measured with a Vernier caliper (SMIEC, China) before and 1 h after carrageenan injection to detect the carrageenan induced inflammation. Each tested compound, at a dose of 0.02 mmol kg -1 , was injected i.p. to thirty four different groups of rats 1 h after carrageenan injection. Control group received the vehicle (1 % The difference between the thicknesses of the two paws was taken as a measure of edema. The measurement was carried out at 0, 0.5, 1, 2, 3, 4 and 5 h after injection of the tested compounds, reference drug and control. The results are listed in Table V .
Gastric ulceration
Ulcerogenicity of the most active anti-inflammatory compounds 6b and 9e was determined on male adult albino rats according to a reported method (22) .
Gastric lesions on the mucosa were determined using a stereoscopic microscope (XJP--XSC-195-40X, Jiangsu, China). Observation of gastrointestinal mucosa for the presence of lesions following oral administration of graded doses of the tested compounds as well as the reference drug was taken as an indication of ulcerogenic effects. Both the frequency of ulceration (expressed as the ratio of ulcerated animals) and the severity of ulceration (expressed as the ulcer index) were used for comparison of the tested compounds and indomethacin. Male albino rats were fasted for 24 h. Compounds 6b, 9e and indomethacin were administered orally at doses of 10, 30, and 50 mg kg -1 as suspensions in a 1 % NaCMC-saline solution to groups of rats of 6 animals each. After 6 h, the animals were sacrificed, the stomachs were removed and gastric lesions on the mucosa were determined using a stereoscopic microscope. Ulcer was defined as at least one lesion of 0.5 mm or more in length. All lesions of more than 0.1 mm in length were summed up to obtain the ulcer index and the results are listed in Table VI .
Acute toxicity
The median lethal dose (LD 50 ) of the most active and safe compounds (6b and 9e) was determined in mice (23) . Groups of male adult albino mice of four animals each, were injected i.p. with graded doses of the tested compounds. The percentage mortality in each group of animals was determined 72 h after the injection.
Partitioning data
The log P values of the tested compounds 5a-e to 10a-c were computed by a routine method called calculated log P (Clog P) (contained in the PC-software package McLogP 2.0, BioByte Corp., CA, USA, Table I ). The molecular structure is entered into the program, which computers the log P based on the fragment method developed by Leo (24) . RESULTS 
AND DISCUSSION

Chemistry
Target compounds, 5-acyl-8-hydroxyquinoline-2-(3'-substituted-4'-aryl-2,3-dihydrothiazol-2'-ylidene) hydrazones 5a-e to 8a-e and 10a-c were prepared by refluxing the appropriate 5-acyl-8-hydroxyquinoline-4-substituted thiosemicarbazones 3a-d and 3f and phenacyl bromides 4a-e in the presence of anhydrous sodium acetate in absolute ethanol. The 5-acetyl-8-hydroxyquinoline-2-(3'-phenyl-4'-aryl-2,3-dihydrothiazol-2'-ylidene) hydrazones 9a-e were prepared by stirring 5-acetyl-8-hydroxyquinoline-4-phenyl thiosemicarbazone 3e with appropriate phenacyl bromide 4a-e in ethanol at room temperature. Structures of the target compounds 5a-e to 10a-c were confirmed by IR, 1 H NMR, MS in addition to elemental analysis. IR spectra of compounds 5a-e to 10a-c were characterized by a lack of characteristic bands of NH and NCS functional groups and exhibited a band attributed to C=N stretching at 1634-1562 cm -1 . Moreover, all compounds showed the characteristic band at 3545-3410 cm -1 (OH stretching of 8-hydroxyquinoline) in addition to its bending at 769-650 cm -1 . 1 H NMR spectra of the prepared products (Table II) showed a general pattern for the 8-hydroxyquinoline characterized by the presence of two doublet signals at 10.17-10.73 ppm and at 9.33-9.80 ppm corresponding to H-2 and H-4 of quinoline, respectively, a multiplet at 7.10-8.93 ppm corresponding to the phenyl group, the OH group (exchangeable), and H-3, H-6 and H-7 of quinoline, a singlet signal at 6.20-6.70 ppm corresponding to the thiazoline proton, and a singlet signal at 2.60-2.90 ppm corresponding to CH 3 , in addition to the disappearance of signals corresponding to the N2-H and N4-H signals. Also, the structure of the target compounds was confirmed by MS of representative compounds 5b, 6c, 7a, 7c, 8b, 9c and 10c. MS for compound 5b revealed the molecular ion peak M + at m/z 452 (63.3 %) corresponding to the relative molecular mass of this compound (452.03) and a base peak at m/z 170 (100 %). It also showed the M + +2 peaks of 81 Br and the 34 S peak at m/z 454 (71.9 %). MS for compound 6c revealed the molecular ion peak M + at m/z 422 (54.2 %) corresponding to the M r of this compound (422.10) and a base peak at m/z 170 (100 %). It also showed the M + +2 peak of 37 Cl and the 34 S peak at m/z 424 (23.7 %). MS for compound 7a revealed the molecular ion peak M + at m/z 400 (100 %) corresponding to the M r of this compound (400.14), which is also the base peak. MS for compound 7c revealed the molecular ion peak M + at m/z 434 (100 %) corresponding to the M r of this compound (434.10), which is also the base peak. It also showed the M + +2 peak of 37 Cl peak at m/z 436 (36.1 %). MS for compound 8b revealed the molecular ion peak M + at m/z 520 (14.8 %) corresponding to the M r of this compound (520.09) and a base peak at m/z 55 (100 %). It also showed the M + +2 peak of 81 Br peak at m/z 522 (14.9 %). MS for compound 9c revealed the molecular ion peak M + at m/z 470 (100 %) corresponding to the M r of this compound (470.10), which is also the base peak. It also showed the M + +2 peak of 37 Cl peak at m/z 472 (38.7 %). MS for compound 10c revealed the molecular ion peak M + at m/z 538 (54.6 %) corresponding to the M r of this compound (538.16) and a base peak at m/z 247 (100 %). It also showed the M + +2 peak of 37 Cl peak at m/z 540 (23.7 %).
Antimicrobial activity
Results of the antibacterial activity (Table III) indicated that M. luteus was completely resistant to the tested compounds, while B. cereus, E. coli and S. marcescens were the most sensitive organisms to the tested compounds.
Compounds 5d, 9d, 9e, 10a and 10b were completely inactive against the tested organisms. Also the test compounds were most inactive against S. aureus and P. aeroginosa except for compounds 7d, 8a, 8b, 8d and 10c. On the other hand, tested compounds were active against B. cereus, E. coli and S. marcescens since they showed 20-88 % antibac-terial activity of that exerted by gatifloxacin. The most active compounds were 5b, 5c, 5e, 7b, 8c, 9a and 9b. The latter contain Cl, Br or OCH 3 as an R 2 substituent. It was also noticed that the introduction of a phenyl group in compounds 9a-e resulted in a decrease of their antibacterial activity. Also, the cyclohexyl substituent at R 1 seems to be crucial for the antibacterial activity.
Results of antifungal activity (Table IV) revealed that all the tested compounds were inactive against T. rubrum. They were also inactive against C. albicans, except for compounds 5e and 8c and against G. candidum, except for compounds 5b, 5c, 5e, and 8c which showed 31-47 % activity compared to ketoconazole. Several compounds showed weak to moderate activity against S. brevicaulis, while the reference drug was completely inactive. Important to say, compounds 5a-c, 5e, 6a, 6b, 6e, 7b and 8c were even more active than ketoconazole against F. oxysporum. The most active compounds were 5c, 6e, 7b, 8c and 9b comprising Cl, Br or OCH 3 as an R 2 substituent.
Anti-inflammatory activity
Results of anti-inflammatory activity (Table V) revealed that all the tested compounds showed a gradual increase of anti-inflammatory activity up to its maximum after 4 h. After 5 h, almost all the newly synthesized compounds showed 51-78 % edema inhibition (edema inhibition of indomethacin at the time is 80.9 %). Accordingly, comparison between the tested compounds was made at the moment of the highest activity. Compounds 3a-f, 5a-e, 6a-e, 7a-e, 8a-e, 9a-e and 10 a-c showed 63-104 % of the anti-inflammatory activity of indomethacin after 4 h.
It is noteworthy that cyclization of thiosemicarbazone derivatives 3a-f into the corresponding thiazoline derivatives 5a-e to 10a-c resulted in a marked increase of anti-inflammatory activity, which is similar to previous findings (21) . Also, most of the compounds bearing p-Cl, p-Br, or p-OCH 3 substituents on the phenyl group showed high anti-inflammatory activity indicating the crucial role of halogen or OCH 3 for anti-inflammatory activity, which is similar to previous data (25) .
Ulcerogenic effect and acute toxicity
The most active anti-inflammatory compounds 6b and 9e and indomethacin were evaluated for their ulcerogenic effect (Table VI) . Data revealed that compounds 6b and 9e had no ulcerogenic effect at the treating doses of 10 and 30 mg kg -1 while at higher doses (50 mg kg -1 ) they exhibited lower ulcerogenic activity compared to indomethacin.
Indomethacin caused ulceration at the tested dose levels and increased in frequency and severity at higher doses.
In addition, the median lethal doses (LD 50 ) of compounds 6b and 9e were evaluated and it was found that they were non-toxic at doses up to 400 mg kg -1 (i.p.) while the reported LD 50 of indomethacin is 13 mg kg -1 (i.p.) (26) . A number of 5-acyl-8-hydroxyquinoline-2-(3'-substituted-4'-aryl-2,3-dihydro-thiazol--2'-ylidene)hydrazones, 5a-e to 10a-c, were prepared and tested for their antibacterial activities. They showed moderate activity against most of the tested bacterial strains but showed no antibacterial activity against M. luteus. The antifungal data of the tested compounds showed that the N-methyl and N-ethyl series were the most active compounds and many compounds showed better antifungal activity against F. oxysporum than ketoconazole; some also showed activity against S. brevicaulis (c.f. ketoconazole). On the other hand, the tested compounds showed a gradual increase in their anti-inflammatory activity, reaching its maximum after 4 h in the carrageenan induced paw edema. Cyclization of thiosemicarbazone derivatives into the corresponding thiazoline derivatives resulted in a marked increase in anti-inflammatory activity. The p-bromo-p-chloro-and p-methoxy-phenyl derivatives showed the highest activity, which indicates the crucial role of halogen or OCH 3 . Compounds 6b,c, 7b,c,e, 8b,e, 9c,e, and 10a,b showed activity comparable to that of indomethacin as the reference drug.
The most active anti-inflammatory compounds 6b and 9e were safer than indomethacin in ulcerogenic liability in frequency and severity. In addition, the LD 50 of compounds 6b and 9e showed that they were non-toxic at doses up to 400 mg kg -1 (i.p.) whereas the LD 50 of indomethacin is only 13 mg kg -1 (i.p.).
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